Market Place
Sourcing Support
All News #Library
Biotech
Ethris In Consortium Getting EUR 148M Eu Commission Contract
25 Feb 2026 //
GLOBENEWSWIRE
Ethris, (DZIF) Partner To Develop Mrna Vaccines
09 Feb 2026 //
PHARMIWEB
Evonik, Ethris Partner to Broaden Nucleic Acid Delivery Options
09 Sep 2025 //
PRESS RELEASE
Ethris Begins Phase 2a Trial of mRNA Candidate ETH47 for Asthma
05 Aug 2025 //
BUSINESSWIRE
Ethris Collaborates with Thermo Fisher for mRNA Tech Access
13 Jun 2025 //
BUSINESSWIRE
Ethris Gets €10M EU4Health Grant for mRNA Candidate ETH47
06 May 2025 //
BUSINESSWIRE
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines
07 Apr 2025 //
CONTRACTPHARMA
Ethris Reports Positive Phase 1 Data On ETH47 For Asthma
30 Jan 2025 //
BUSINESSWIRE
Ethris` inhaled mRNA-based asthma drug ups its target protein without toxicity
28 Jun 2024 //
FIERCE BIOTECH
Cipla EU to invest an additional € 3 million in Ethris
19 Jun 2024 //
INDIANPHARMAPOST
Ethris Joins Alliance for mRNA Medicines as a Founding Member
01 Nov 2023 //
GLOBENEWSWIRE
DIOSynVax & Ethris Publish Preclinical Proof of Concept for Vaccine Technologies
25 Sep 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.